These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23541442

  • 1. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.
    Valente AJ, Yoshida T, Izadpanah R, Delafontaine P, Siebenlist U, Chandrasekar B.
    Cell Signal; 2013 Jun; 25(6):1447-56. PubMed ID: 23541442
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
    Valente AJ, Yoshida T, Murthy SN, Sakamuri SS, Katsuyama M, Clark RA, Delafontaine P, Chandrasekar B.
    Am J Physiol Heart Circ Physiol; 2012 Aug 01; 303(3):H282-96. PubMed ID: 22636674
    [Abstract] [Full Text] [Related]

  • 4. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ, Clark RA, Siddesha JM, Siebenlist U, Chandrasekar B.
    J Mol Cell Cardiol; 2012 Jul 01; 53(1):113-24. PubMed ID: 22575763
    [Abstract] [Full Text] [Related]

  • 5. The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
    Sukhanov S, Higashi Y, Yoshida T, Mummidi S, Aroor AR, Jeffrey Russell J, Bender SB, DeMarco VG, Chandrasekar B.
    Cell Signal; 2021 Jan 01; 77():109825. PubMed ID: 33160017
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.
    Mummidi S, Das NA, Carpenter AJ, Yoshida T, Yariswamy M, Mostany R, Izadpanah R, Higashi Y, Sukhanov S, Noda M, Siebenlist U, Rector RS, Chandrasekar B.
    J Cell Physiol; 2019 Dec 01; 234(12):22242-22259. PubMed ID: 31074012
    [Abstract] [Full Text] [Related]

  • 8. OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators.
    Valente AJ, Irimpen AM, Siebenlist U, Chandrasekar B.
    Free Radic Biol Med; 2014 May 01; 70():117-28. PubMed ID: 24561578
    [Abstract] [Full Text] [Related]

  • 9. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells.
    Pozo M, de Nicolás R, Egido J, González-Cabrero J.
    Eur J Pharmacol; 2006 Oct 24; 548(1-3):53-63. PubMed ID: 16973154
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.
    Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valente AJ.
    J Biol Chem; 2006 Jun 02; 281(22):15099-109. PubMed ID: 16554298
    [Abstract] [Full Text] [Related]

  • 11. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
    Somanna NK, Valente AJ, Krenz M, Fay WP, Delafontaine P, Chandrasekar B.
    J Cell Physiol; 2016 May 02; 231(5):1130-41. PubMed ID: 26445208
    [Abstract] [Full Text] [Related]

  • 12. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
    Liang YJ, Shyu KG, Wang BW, Lai LP.
    Cardiology; 2008 May 02; 110(3):182-90. PubMed ID: 18057884
    [Abstract] [Full Text] [Related]

  • 13. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
    Chen MC, Tsai YC, Tseng JH, Liou JJ, Horng S, Wen HC, Fan YC, Zhong WB, Hsu SP.
    Int J Mol Sci; 2017 Dec 13; 18(12):. PubMed ID: 29236027
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
    Shyu KG, Chen SC, Wang BW, Cheng WP, Hung HF.
    Clin Sci (Lond); 2012 Jan 13; 122(1):33-42. PubMed ID: 21806545
    [Abstract] [Full Text] [Related]

  • 15. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H, Rimpelová S, Knejzlík Z, Šáchová J, Kolář M, Strnad H, Repiská V, D'Acunto WC, Ruml T, Vítek L.
    Lipids Health Dis; 2017 Dec 20; 16(1):250. PubMed ID: 29262834
    [Abstract] [Full Text] [Related]

  • 16. Simvastatin decreases IL-6 and IL-8 production in epithelial cells.
    Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y.
    J Dent Res; 2006 Jun 20; 85(6):520-3. PubMed ID: 16723648
    [Abstract] [Full Text] [Related]

  • 17. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells.
    Padilla J, Carpenter AJ, Das NA, Kandikattu HK, López-Ongil S, Martinez-Lemus LA, Siebenlist U, DeMarco VG, Chandrasekar B.
    Am J Physiol Heart Circ Physiol; 2018 Jan 01; 314(1):H52-H64. PubMed ID: 28971844
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation.
    Park SY, Lee JS, Ko YJ, Kim AR, Choi MK, Kwak MK, Choi HG, Yong CS, Kim JA.
    Arch Pharm Res; 2008 Feb 01; 31(2):195-204. PubMed ID: 18365690
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.